Efficacy of two dose regimes of intravenous immunoglobulin in rh hemolytic disease of newborn - A randomized controlled trial

Indian Pediatrics

Volumn 45, Issue 8, 2008, Pages 653-659

  Girish, G ^a   Chawla, D ^a   Agarwal, R ^a   Paul, V K ^a   Deorari, Ashok K ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Exchange blood transfusion; Hyperbilirubinemia; Intravenous immunoglobulin; Neonate; Phototherapy; Rh isoimmunization

Indexed keywords

IMMUNOGLOBULIN;

ARTICLE; BLOOD GROUP; CLINICAL ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED STUDY; COOMBS TEST; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; ERYTHROCYTE TRANSFUSION; EXCHANGE BLOOD TRANSFUSION; GESTATIONAL AGE; HOSPITALIZATION; HUMAN; LOW DRUG DOSE; MALE; NEWBORN; NEWBORN HEMOLYTIC DISEASE; PHOTOTHERAPY; RHESUS ISOIMMUNIZATION; TERTIARY HEALTH CARE; TREATMENT DURATION;

ERYTHROBLASTOSIS, FETAL; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT, NEWBORN; RH-HR BLOOD-GROUP SYSTEM;

EID: 48949094609     PISSN: 00196061     EISSN: 00196061     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Gupte SC, Kulkarni SS. Incidence of Rh immunization between 1981 and 1992. Natl Med J India 1994; 7: 65-66.
2. Rübo J, Albrecht K, Lasch P, Laufkötter E, Leititis J, Marsan D, et al. High-dose intravenous immune globulin therapy for hyperbilirubinaemia caused by Rh hemolytic disease. J Pediatr 1992; 121: 93-97.
3. Dagoglu T, Ovali F, Samanci N, Bengisu E. High-dose intravenous immunoglobulin therapy for rhesus haemolytic disease. J Int Med Res 1995; 23: 264-271.
4. Alpay F, Sarici SU, Okutan V, Erdem G, Ozcan O, Gokcay E. High-dose intravenous immunoglobulin therapy in neonatal immune hemolytic jaundice. Acta Paediatr 1999; 88: 216-219.
5. Voto L, Sexer H, Ferreiro G, Tavosnanska J, Orti J, Mathet E, et al. Neonatal administration of high dose intravenous immunoglobulin in rhesus hemolytic disease. Perinat Med 1995; 23: 443-451.
6. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004; 114: 297-316.
7. Mukhopadhyay K, Murki S, Narang A, Dutta S. Intravenous immunoglobulin in rhesus hemolytic disease. Indian J Pediatr 2003; 70: 697-699.
8. Tanyer G, Siklar Z, Dallar Y, Yildirmak Y, Tiras U. Multiple dose IVIG treatment in neonatal immune hemolytic jaundice. J Trop Pediatr 2001; 47: 50-53.
9. Research Randomizer. Available from: URL: http:// randomizer.org/form. htm. Accessed December 25, 2005.
10. Ballard JL, Khoury JC, Wedig K, Wang L, Eilers-Walsman BL, Lipp R. New Ballard Score, expanded to include extremely premature infants. J Pediatr 1991; 119: 417-423.
11. Arya VB, Agarwal R, Paul VK, Deorari AK. Efficacy of oral phenobarbitone in term "at risk" neonates in decreasing neonatal hyperbilirubinemia: a randomized double-blinded, placebo controlled trial. Indian Pediatr 2004; 41: 327-332.
12. Gottstein R, Cooke RW. Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn. Arch Dis Child Fetal Neonatal Ed 2003; 88: F6-F10.
13. Janssens HM, de Haan MJ, van Kamp IL, Brand R, Kanhai HH, Veen S. Outcome for children treated with fetal intravascular transfusions because of severe blood group antagonism. J Pediatr 1997; 131: 373-380.